{"id":"https://openalex.org/W2407057693","doi":"https://doi.org/10.3760/cma.j.issn.1007-3418.2012.02.006","title":"[Efficacy of lamivudine and adefovir de novo combination therapy or after mono-therapy in chronic hepatitis B patients].","display_name":"[Efficacy of lamivudine and adefovir de novo combination therapy or after mono-therapy in chronic hepatitis B patients].","publication_year":2012,"publication_date":"2012-02-01","ids":{"openalex":"https://openalex.org/W2407057693","doi":"https://doi.org/10.3760/cma.j.issn.1007-3418.2012.02.006","mag":"2407057693","pmid":"https://pubmed.ncbi.nlm.nih.gov/22464779"},"language":"zh","primary_location":{"id":"pmid:22464779","doi":"https://doi.org/10.3760/cma.j.issn.1007-3418.2012.02.006","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22464779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100976816","display_name":"Xiaojun Ma","orcid":"https://orcid.org/0009-0002-3812-0473","observed_orcids":["https://orcid.org/0009-0002-3812-0473"]},"institutions":[{"id":"https://openalex.org/I2799425052","display_name":"Guangdong General Hospital","ror":"https://ror.org/03jpekd50","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2799425052"]},{"id":"https://openalex.org/I4210145693","display_name":"Guangdong Academy of Medical Sciences","ror":"https://ror.org/0432p8t34","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210145693"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiao-Jun Ma","raw_affiliation_strings":["Department of Infectious Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China","institution_ids":["https://openalex.org/I2799425052","https://openalex.org/I4210145693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100462202","display_name":"Xiaoping Chen","orcid":"https://orcid.org/0000-0002-2910-9152","observed_orcids":["https://orcid.org/0000-0002-2910-9152"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiao-Ping Chen","raw_affiliation_strings":["510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006126602","display_name":"Xue-Fu Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xue-Fu Chen","raw_affiliation_strings":["510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031292783","display_name":"Wenli Chen","orcid":"https://orcid.org/0000-0002-4768-3844","observed_orcids":["https://orcid.org/0000-0002-4768-3844"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wen-Li Chen","raw_affiliation_strings":["510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022165930","display_name":"Jing Huang","orcid":"https://orcid.org/0000-0003-3587-2370","observed_orcids":["https://orcid.org/0000-0003-3587-2370"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Huang","raw_affiliation_strings":["510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ren Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ren Chen","raw_affiliation_strings":["510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080152413","display_name":"Xiaodan Luo","orcid":"https://orcid.org/0000-0002-3225-502X","observed_orcids":["https://orcid.org/0000-0002-3225-502X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiao-Dan Luo","raw_affiliation_strings":["510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"510080\u5e7f\u5dde,\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\u5e7f\u4e1c\u7701\u533b\u5b66\u79d1\u5b66\u9662\u611f\u67d3\u79d1","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033210183","display_name":"Hongying Ma","orcid":"https://orcid.org/0000-0001-6846-4125","observed_orcids":["https://orcid.org/0000-0001-6846-4125"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong-Ying Ma","raw_affiliation_strings":["\u5e7f\u5dde,\u89e3\u653e\u519b\u7b2c\u56db\u4e8c\u4e00\u533b\u9662\u6d88\u5316\u5185\u79d1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u5e7f\u5dde,\u89e3\u653e\u519b\u7b2c\u56db\u4e8c\u4e00\u533b\u9662\u6d88\u5316\u5185\u79d1","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2106,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.54503006,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"20","issue":"2","first_page":"98","last_page":"102"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10337","display_name":"Liver Disease and Transplantation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9309999942779541},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adefovir","display_name":"adefovir","score":0.9860000014305115},{"id":"https://openalex.org/keywords/combination-antiviral-therapy","display_name":"combination antiviral therapy","score":0.9290000200271606},{"id":"https://openalex.org/keywords/hbv-dna-suppression","display_name":"HBV DNA suppression","score":0.8870000243186951},{"id":"https://openalex.org/keywords/viral-breakthrough","display_name":"viral breakthrough","score":0.6660000085830688},{"id":"https://openalex.org/keywords/hbeag-seroconversion","display_name":"HBeAg seroconversion","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hbeag-loss","display_name":"HBeAg loss","score":0.4909999966621399},{"id":"https://openalex.org/keywords/hbsag-loss","display_name":"HBsAg loss","score":0.5889999866485596},{"id":"https://openalex.org/keywords/treatment-switching","display_name":"treatment switching","score":0.35899999737739563},{"id":"https://openalex.org/keywords/antiviral-efficacy","display_name":"antiviral efficacy","score":0.640999972820282},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.49900001287460327},{"id":"https://openalex.org/keywords/aminotransferases","display_name":"transaminases","score":0.42899999022483826},{"id":"https://openalex.org/keywords/liver-histopathology","display_name":"liver histopathology","score":0.33899998664855957}],"concepts":[{"id":"https://openalex.org/C2779517838","wikidata":"https://www.wikidata.org/wiki/Q353551","display_name":"Adefovir","level":5,"score":0.9702440500259399},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.9038063287734985},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8614518642425537},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.814261794090271},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.698991596698761},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6716247797012329},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.5491722226142883},{"id":"https://openalex.org/C2993512173","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral therapy","level":4,"score":0.5006053447723389},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.48443129658699036},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.4807179272174835},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.4230729937553406},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2943694591522217},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.24423658847808838}],"mesh":[{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:22464779","doi":"https://doi.org/10.3760/cma.j.issn.1007-3418.2012.02.006","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22464779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology","raw_type":"Comparative Study"},{"id":"mag:2407057693","doi":"https://doi.org/10.3760/cma.j.issn.1007-3418.2012.02.006","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22464779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1984790250","https://openalex.org/W2366080714","https://openalex.org/W3032101733","https://openalex.org/W2113513788","https://openalex.org/W2005015841","https://openalex.org/W3030659113","https://openalex.org/W2143495498","https://openalex.org/W1958888652","https://openalex.org/W2359728855","https://openalex.org/W2395369610"],"abstract_inverted_index":{"To":[0],"investigate":[1],"the":[2,67,85,88,104,112,114,126,149,178,181,209,326,329,358],"efficacy":[3],"of":[4,7,27,42,144,211,334],"104":[5,79,170,196,234,260,298,367],"weeks":[6,26,96,138,368],"lamivudine":[8,30],"(LAM)":[9],"and":[10,58,131,140,154,165,167,174,191,193,200,220,231,245,258,293,295,314,375,378],"adefovir":[11,32],"(ADV)":[12],"de":[13,362],"novo":[14,363],"combination":[15,21,62,123,156,364],"therapy,":[16],"as":[17],"compared":[18,346],"to":[19,111,122],"optimized":[20],"therapy":[22,124,157,365],"administered":[23],"after":[24,102],"48":[25,95,139,161,187,225,250,277],"treatment":[28,52],"with":[29,45,74,97,347,372],"or":[31,87,99,120,349],"mono-therapy,":[33,151,153],"in":[34,66,84,148],"chronic":[35],"hepatitis":[36,268],"B":[37,269],"(CHB)":[38],"patients.":[39],"A":[40],"total":[41],"174":[43],"patients":[44,65,83,318,371],"CHB":[46,370],"were":[47,72,91,134,162,171,188,197,278,299,337],"equally":[48],"divided":[49],"among":[50,317,328],"three":[51,330],"groups:":[53],"LAM":[54,59,68,75,86,98,150,216,221,241,348,359],"mono-therapy;":[55,57],"ADV":[56,61,70,77,89,152,218,243,350,361],"+":[60,69,217,242],"therapy.":[63],"The":[64,82,142,267],"group":[71,219,222,244,247],"treated":[73,93],"plus":[76,360],"for":[78,94,125,208,320,332,366],"consecutive":[80],"weeks.":[81,129],"groups":[90,158,331],"first":[92],"ADV,":[100],"respectively,":[101,316],"which":[103],"patient's":[105],"virological":[106,374],"response":[107],"was":[108,116],"assessed.":[109],"According":[110],"results,":[113],"patient":[115],"continued":[117],"on":[118],"mono-therapy":[119,351],"switched":[121],"subsequent":[127],"56":[128],"Virological":[130],"biochemical":[132],"examinations":[133],"carried":[135],"out":[136],"at":[137,159,168,185,194,223,232,248,275,296,355],"104.":[141],"rates":[143,184,274],"undetectable":[145,212],"HBV":[146,213],"DNA":[147,214],"LAM-ADV":[155],"week":[160,169,186,195,224,233,249,259,276,297,356],"68%,":[163],"50%,":[164],"84%,":[166],"80%,":[172],"72%,":[173],"95%,":[175],"respectively.":[176,202],"For":[177],"same":[179],"groups,":[180],"virus":[182],"breakthrough":[183],"15%,":[189],"0%,":[190,192,201],"18%,":[198],"2%,":[199],"Statistical":[203,322],"analysis":[204,323],"showed":[205,324],"significant":[206,339],"differences":[207,327],"rate":[210],"between":[215],"(x2":[226,235,251,261,280,287,301,308],"=":[227,236,239,252,262,265,281,284,288,291,302,305,309,312],"4.473,":[228],"P=":[229],"0.034)":[230],"5.795,":[237],"P":[238,254,264,283,290,304,311,341],"0.016),":[240],"ADM":[246],"14.802,":[253],"less":[255,342],"than":[256,343],"0.001)":[257],"5.547,":[263],"0.001).":[266],"e":[270],"antigen":[271],"(HBeAg)":[272],"seroconversion":[273],"15%":[279],"4.543,":[282],"0.033),":[285],"13%":[286],"4.035,":[289],"0.045)":[292],"38%,":[294],"21%":[300],"4.438,":[303],"0.035),":[306],"17%":[307],"4.223,":[310],"0.04)":[313],"44%,":[315],"positive":[319],"HBeAg.":[321],"that":[325],"each":[333],"these":[335],"parameters":[336],"statistically":[338],"(all,":[340],"0.05).":[344],"When":[345],"followed":[352],"by":[353],"LAM+ADV":[354],"48,":[357],"provided":[369],"better":[373],"serological":[376],"responses":[377],"a":[379],"lower":[380],"drug":[381],"resistance":[382],"rate.":[383]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2016-06-24T00:00:00"}